Active Biotech AB (OSTO:ACTI) Short-Term Capital Lease Obligation : kr1.55 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Short-Term Capital Lease Obligation?

Active Biotech AB's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr1.55 Mil.

Active Biotech AB's quarterly Short-Term Capital Lease Obligation stayed the same from Jun. 2023 (kr0.00 Mil) to Sep. 2023 (kr0.00 Mil) but then increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr1.55 Mil).

Active Biotech AB's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (kr0.76 Mil) to Dec. 2022 (kr1.61 Mil) but then declined from Dec. 2022 (kr1.61 Mil) to Dec. 2023 (kr1.55 Mil).

Active Biotech AB Short-Term Capital Lease Obligation Historical Data

The historical data trend for Active Biotech AB's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Short-Term Capital Lease Obligation Chart

Active Biotech AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.25

1.31

0.76

1.61

1.55

Active Biotech AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.61	-	-	-	1.55

Active Biotech AB Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Active Biotech AB Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Active Biotech AB (OSTO:ACTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

BTPC:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.activebiotech.com

Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines